Trial Profile
A Prospective, Randomized Study to Compare the Effect of Campath-1, Low Dose Sirolimus Versus Campath-1H, Low Dose CsA Both in Addition to Low Dose Mycophenolate Mofetil on Phenotypic and Functional Profiles of PBMCs in Kidney Transplant Recipients in a Steroid-Free Regimen
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Alemtuzumab (Primary) ; Ciclosporin; Methylprednisolone; Mycophenolate mofetil; Sirolimus
- Indications Renal transplant rejection
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- 06 Apr 2009 New trial record